Nada S. Ibrahim
About
Nada S. Ibrahim is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology.
According to data from OpenAlex, Nada S. Ibrahim has authored 24 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 4 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Nada S. Ibrahim's work include Synthesis and biological activity (22 papers), Synthesis and Characterization of Heterocyclic Compounds (9 papers) and Synthesis and Biological Evaluation (9 papers). Nada S. Ibrahim is often cited by papers focused on Synthesis and biological activity (22 papers), Synthesis and Characterization of Heterocyclic Compounds (9 papers) and Synthesis and Biological Evaluation (9 papers). Nada S. Ibrahim collaborates with scholars based in Egypt, Saudi Arabia and Italy. Nada S. Ibrahim's co-authors include Ismail A. Abdelhamid, Ahmed H. M. Elwahy, Magda F. Mohamed, Farid M. Sroor, Karima F. Mahrous, Mostafa E. Salem, Abdel Hady A. Abdel Wahab, Mohammed A. El‐Magd, Hamdi M. Hassaneen and Abdelmageed M. Othman and has published in prestigious journals such as Scientific Reports, Chemico-Biological Interactions and Naunyn-Schmiedeberg s Archives of Pharmacology.
In The Last Decade
Nada S. Ibrahim
24 papers receiving 373 citations
Peers
Nada S. Ibrahim
Sridevi Gorle South Africa
Magdy M. Hemdan Egypt
Nadia Y. Megally Abdo Egypt
Lalita Guntuku India
Anhar Abdel‐Aziem Egypt
Teresa Glomb Poland
Sumitra Nain India
Mahmoud F. Ismail Egypt
Amira A. El‐Sayed Egypt
Xiang-Jing Fu China
Citations per year, relative to Nada S. Ibrahim Nada S. Ibrahim (= 1×)
peers
Sridevi Gorle
Countries citing papers authored by Nada S. Ibrahim
Since
Specialization
Citations
This map shows the geographic impact of Nada S. Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada S. Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada S. Ibrahim more than expected).
Fields of papers citing papers by Nada S. Ibrahim
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nada S. Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada S. Ibrahim. The network helps show where Nada S. Ibrahim may publish in the future.
Co-authorship network of co-authors of Nada S. Ibrahim
This figure shows the co-authorship network connecting the top 25 collaborators of Nada S. Ibrahim. A scholar is included among the top collaborators of Nada S. Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nada S. Ibrahim. Nada S. Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ibrahim, Nada S., et al.. (2025). Synthesis, cytotoxicity, antiproliferative, antioxidant, anti-inflammatory, and anti-metastatic activities of novel 2-arylidene-indane-1,3-dione scaffolds incorporating 2-phenoxy-N-arylacetamide moiety: Induction of apoptosis in Hela cells. Journal of Molecular Structure. 1328. 141424–141424.
2.
Salem, Mostafa E., et al.. (2025). Synthesis, molecular docking simulation, and antimicrobial activities of novel fused pyrimidine systems linked to N-arylacetamide and vanillin units as novel hybrid molecules via Hantzsch and Biginelli reactions. Journal of Molecular Structure. 1339. 142345–142345.
3.
Elwahy, Ahmed H. M., et al.. (2025). Synthesis, and antibacterial activities of novel 1,3,4a,9-tetraza-4H-fluoren-2-amines incorporating phenoxy-N-arylacetamide, pyrazole, and 2-(4-(1-phenyl-1H-pyrazol-3-yl)phenoxy)-N-arylacetamide moieties. BMC Chemistry. 19(1). 61–61.
4.
Ibrahim, Nada S., et al.. (2025). Synthesis, cytotoxicity, oxidative stress, anti-metastatic and anti-inflammatory effects of novel 2-methylene-1H-indene-1,3-dione tethered 2-(2-methoxyphenoxy)-N-arylacetamide: induction of apoptosis in HCT116 and HeLa cells. Chemico-Biological Interactions. 416. 111549–111549.
5.
Ibrahim, Nada S., et al.. (2024). Synthesis, molecular docking, and antimicrobial activity of novel scaffolds based on bis(thiazole) linked to 2-phenoxy-N-arylacetamide as new hybrid molecules. Journal of Molecular Structure. 1302. 137506–137506.
6.
Abdelhamid, Ismail A., et al.. (2024). Synthesis, molecular docking simulation, and antimicrobial activities of novel bis-heterocycles linked to piperazine and vanillin units as novel hybrid molecules via Hantzsch, Biginelli, and Michael’s reactions. Results in Chemistry. 10. 101684–101684.
7.
Elwahy, Ahmed H. M., et al.. (2024). Synthesis and antibacterial activities of novel hybrid molecules based on benzothiazole, benzimidazole, benzoxazole, and pyrimidine derivatives, each connected to N-arylacetamide and benzoate groups. Journal of Molecular Structure. 1307. 137965–137965.
8.
Ibrahim, Nada S., et al.. (2024). Synthesis, cytotoxicity, anti-inflammatory, anti-metastatic and anti-oxidant activities of novel chalcones incorporating 2-phenoxy-N-arylacetamide and thiophene moieties: induction of apoptosis in MCF7 and HEP2 cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(12). 10091–10107.
9.
Sroor, Farid M., et al.. (2023). In silico and in vitro studies of novel cyanoacrylamides incorporating pyrazole moiety against breast and prostate carcinomas. Medicinal Chemistry Research. 32(6). 1190–1203.
10.
Salem, Mostafa E., et al.. (2023). Novel Scaffolds Based on Bis-thiazole Connected to Quinoxaline or Thienothiophene through 2-Phenoxy-N-arylacetamide Groups as New Hybrid Molecules: Synthesis, Antibacterial Activity, and Molecular Docking Investigations. ACS Omega. 8(46). 44312–44327.
11.
Sroor, Farid M., et al.. (2023). Design, synthesis, in vitro anticancer, molecular docking and SAR studies of new series of pyrrolo[2,3-d]pyrimidine derivatives. BMC Chemistry. 17(1). 106–106.
12.
Sroor, Farid M., et al.. (2023). Impact of trifluoromethyl and sulfonyl groups on the biological activity of novel aryl-urea derivatives: synthesis, in-vitro, in-silico and SAR studies. Scientific Reports. 13(1). 17560–17560.
13.
Salem, Mostafa E., et al.. (2023). Novel diphenyl ether-heterocycles hybrids: Synthesis via Hantzsch and Biginelli reactions, molecular docking simulation, and antimicrobial activities. Journal of Molecular Structure. 1296. 136857–136857.
14.
Mohamed, Magda F., Nada S. Ibrahim, Amna A. Saddiq, & Ismail A. Abdelhamid. (2023). Novel 3-(pyrazol-4-yl)-2-(1H-indole-3-carbonyl)acrylonitrile derivatives induce intrinsic and extrinsic apoptotic death mediated P53 in HCT116 colon carcinoma. Scientific Reports. 13(1). 22486–22486.
15.
Mohamed, Magda F., Nada S. Ibrahim, Amna A. Saddiq, et al.. (2022). Theoretical and molecular mechanistic investigations of novel (3-(furan-2-yl)pyrazol-4-yl) chalcones against lung carcinoma cell line (A549). Naunyn-Schmiedeberg s Archives of Pharmacology. 396(4). 719–736.
16.
Mohamed, Magda F., Nada S. Ibrahim, Sherif Ibrahim, et al.. (2021). Cytotoxic Activity, Apoptosis Induction and Cell Cycle Arrest in Human Breast Cancer (MCF7) Cells by a Novel Fluorinated Tetrahydro-[1,2,4]Triazolo[3,4- a ]Isoquinolin Chalcones. Polycyclic aromatic compounds. 43(1). 268–287.
17.
Mohamed, Magda F., Amna A. Saddiq, Turki M. Al-Shaikh, Nada S. Ibrahim, & Ismail A. Abdelhamid. (2021). Computational studies and sever apoptotic bioactivity of new heterocyclic cyanoacrylamide based p-fluorophenyl and p-phenolic compounds against liver carcinoma (Hepg2). Bioorganic Chemistry. 114. 105147–105147.
18.
El‐Magd, Mohammed A., Ismail A. Abdelhamid, Magda F. Mohamed, et al.. (2021). Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells. Bioorganic Chemistry. 116. 105329–105329.
19.
Mohamed, Magda F., Farid M. Sroor, Nada S. Ibrahim, et al.. (2020). Novel [l,2,4]triazolo[3,4-a]isoquinoline chalcones as new chemotherapeutic agents: Block IAP tyrosine kinase domain and induce both intrinsic and extrinsic pathways of apoptosis. Investigational New Drugs. 39(1). 98–110.
20.
Abdelmoniem, Amr M., et al.. (2019). Synthesis, Cytotoxicity and Molecular Docking Simulation of Novel bis-1,4-Dihydropyridines Linked to Aliphatic or Arene Core via Amide or Ester-Amide Linkages. Mini-Reviews in Medicinal Chemistry. 20(9). 801–816.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sridevi Gorle Breakdown of academic impact, for papers by Magdy M. Hemdan Breakdown of academic impact, for papers by Nadia Y. Megally Abdo Breakdown of academic impact, for papers by Lalita Guntuku Breakdown of academic impact, for papers by Anhar Abdel‐Aziem Breakdown of academic impact, for papers by Teresa Glomb Breakdown of academic impact, for papers by Sumitra Nain Breakdown of academic impact, for papers by Mahmoud F. Ismail Breakdown of academic impact, for papers by Amira A. El‐Sayed Breakdown of academic impact, for papers by Xiang-Jing Fu